Showing results (71-80 of 92) with videos related to
Sort By:
Pageof 10
The Annals of Thoracic Surgery|July 1, 1994
Predictive value of blood clotting tests in cardiac surgical patientsG P Gravlee, S Arora, S W Lavender, et al.American Journal of Clinical Oncology|October 1, 1983
Vincristine by continuous infusion in refractory breast cancer: a phase II studyJ O Hopkins, D V Jackson, D R White, et al.American Journal of Clinical Oncology|June 1, 1983
Lack of potentiation of vincristine-induced neurotoxicity by VP-16-213D V Jackson, H B Wells, D R White, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1986
Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont Oncology AssociationF Richards, L D Case, D R White, et al.American Journal of Clinical Oncology|February 1, 1984
Bone marrow evaluation in small cell lung cancerH B Muss, D V Jackson, F Richards, et al.Cancer|April 15, 1981
Cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil in advanced prostatic cancer: a randomized trialH B Muss, V Howard, F Richards, et al.Cancer|May 1, 1981
Chemotherapy vs. chemoimmunotherapy with methanol extraction residue of Bacillus Calmette-Guerin (MER) in advanced breast cancer: a randomized trial by the Piedmont Oncology AssociationH B Muss, F Richards, M R Cooper, et al.Cancer|June 15, 1984
Treatment of advanced non-Hodgkin's lymphoma with vincristine infusionD V Jackson, E H Paschold, C L Spurr, et al.Seminars in Oncology|March 1, 1985
Megestrol acetate v tamoxifen in advanced breast cancer: a phase III trial of the Piedmont Oncology Association (POA)H B Muss, E H Paschold, W R Black, et al.Blood|March 1, 1984
Treatment of poor risk acute leukemia with sequential high-dose ARA-C and asparaginaseR L Capizzi, M Poole, M R Cooper, et al.Pageof 10